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Drug resistanceAbstract Objective: Pathogen distribution characteristics of nephrology patients with urinary tract
infections are studied, and drug resistance of nephrology and urinary tract infection disease are ana-
lyzed, so as to provide sufficient evidence for treatment of patients. Methods: Conduct randomized
control study of 3500 cases of nephrology patients with urinary tract infections treated in different
hospitals from December 2013 to December 2015, isolate pathogens in patients’ urine samples, per-
form identification and drug sensitive test and then conduct detailed analysis of drug resistance of
pathogens. Results: Through isolation of pathogens, it can be found that all pathogens include
Escherichia coli, Gram-positive cocci, gram-negative bacteria, fungi, Acinetobacter baumannii,
Enterococcus faecalis, and urinary Enterococcus. Among them, proportion of E. coli is the largest.
Patients have relatively high drug resistance to ceftriaxone, gentamicin, ciprofloxacin and cotrimox-
azole. Conclusion: For nephrology patients with urinary tract infection, the main pathogen is
E. coli, which has had some drug resistance. Drug resistance detection of pathogen should be
strengthened in clinics, so as to provide strong guidance for clinical treatment and promote effective
treatment of patients.
 2016 Production and Hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Nephrology disease is kidney based disease of many patients.
Nephrology diseases mainly include acute nephritis, chronic
kidney disease and urinary tract infections. Nephrology dis-
ease can lead to decline in patients’ own immune system,resulting in poor application condition of patients and serious
infections. Urinary tract infection is a common infection of
nephrology disease, which causes a very serious impact on
health of patients with nephrology disease. Therefore, analysis
of pathogen distribution of nephrology patients with urinary
tract infection should be strengthened, so as to realize diagno-
sis and treatment of urinary tract infection, and effectively
improve treatment of urinary tract infections, which can pro-
mote effective recovery of nephrology patients with urinary
tract infection. The pathogens under microscope is shown in
Fig. 1.
Figure 2 Drug sensitive test.Figure 1 Pathogens under microscope.
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2.1. General information
The 3500 cases of nephrology patients admitted in different
hospitals during December 2013–December 2015 were studied,
and pathogen characteristics of urinary tract infection patients
were studied. All samples of pathogens were provided by Clin-
ical Laboratory Center of Ministry of Health.
2.2. Select appropriate instruments and reagents
Automated microbial analyzer produced in France was
adopted for sample analysis, to be equipped with the appropri-
ate bacterial identification and drug sensitive identification
card.
2.3. Conduct drug sensitive test
Conduct drug sensitive test of samples in accordance with cor-
responding steps, with operation methods following corre-
sponding operating instructions, and determine based on low
drug sensitivity results of CLSI-S20 monitoring standards.
The drug sensitive test is shown in Fig. 2.
3. Results
3.1. Pathogen distribution of urinary tract infection patients
Among nephrology patients, a total of 3500 pathogens, 750
Gram-negative bacteria, 1060 Escherichia coli, 770 Klebsiella
pneumoniae, 650 Gram-positive bacteria and 270 Acinetobacter
baumannii were isolated.
3.2. Discussion of drug resistance of pathogens
E. coli, a common pathogen of sample pathogen of urinary
tract infection patients, can have some resistance to drugs such
as ceftriaxone, cefazolin, gentamicin and ciprofloxacin. E. coli
is a common type of pathogen. Effective study of drug resis-
tance of E. coli can strengthen clinical treatment of nephrology
patients with urinary tract infection, and then improve clinicaloutcomes of patients, which is in favor of patients’ body
health. The E. coli under microscope is shown in Fig. 3.
Enterococcus faecalis have strong drug resistance to tetracy-
cline, erythromycin. Enterococcus faecium can have relatively
strong resistance to penicillin, erythromycin and ciprofloxacin.
E. faecalis and Staphylococcus epidermidis have relatively sen-
sitive drug resistance. Hospitalized nephrology patients, espe-
cially during hospitalization after dialysis, will have serious
infections, which is mainly respiratory tract infection, followed
by urinary tract infection. During urinary tract infection, due
to relatively complex physiological structure, the majority is
caused by parasitic flora in intestinal tract, of which E. coli
occupies absolute advantage. In the course of the study,
among isolated pathogens, E. coli, ceftriaxone resistance rate
is relatively high, which is relatively sensitive to ceftazidime
of third-generation cephalosporin, with relatively strong resis-
tance. E. coli can produce corresponding drug resistance to
quinolone. In recent years, clinical application of fluoro-
quinolones has been continuously strengthened; then, bacterial
resistance to these drugs has gradually strengthened, and dif-
ferent resistance strains can exhibit cross-resistance for differ-
ent varieties.
E. faecalis, one of the most common Gram-positive coccus
in urinary tract infection, is with relatively strong drug resis-
tance to erythromycin and tetracycline. Therefore, in treat-
ment of infection caused by E. faecalis, erythromycin and
tetracycline should be avoided for treatment. Nitrofurantoin
and stubborn miso also have good sensitivity to urinary tract
infections caused by E. faecalis. E. faecalis can produce natural
resistance to a variety of antibiotics, and emergence of van-
comycin strains also provides some guidance for clinical treat-
ment and laboratories. Infection caused by E. faecalis has
clinically shown a significant upward trend in recent years.
During clinical medicine testing and treatment, bacteriological
examination and drug sensitivity test should be strengthened,
so that such pathogen phenomenon can be effectively con-
trolled and then infections can be effectively controlled
(Chen et al., 2014). The E. faecalis under microscope is shown
in Fig. 4.
After nephrology patients have urinary tract infections,
major disease pathogens feature E. coli and K. pneumoniae of
Grand negative bacteria. Such pathogens have a strong resis-
tance for cephalosporin and penicillin drugs, which brings
some difficulties for treatment work. However, this pathogen
Figure 4 Enterococcus faecalis under microscope.
Figure 3 Escherichia coli under microscope.
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resistance is relatively low. Amikacin drugs have relatively
strong renal toxicity, which will increase renal impairment of
renal tubular patient in the use process (Wang, 2014). There-
fore, during treatment of nephrology urinary tract infection,
treatment method should be carefully selected so as to improve
safety of treatment work. Although imipenem is with a certain
security in treatment of patients with urinary tract infection,
price of this drug is actually relatively high, which will cause
serious economic pressure for some patients with financial dif-
ficulties and thus is unacceptable. Therefore, based on overall
consideration of a number of factors, piperacillin and nitrofu-
rantoin should be selected so as to effectively treat urinary
tract infection patients (Liu, 2014). Meanwhile, in the clinical
treatment of urinary tract infections, aseptic technique should
also be strengthened, and improper operation should be
avoided to effectively evade urinary tract infections caused
by non-standard operation (Yu et al., 2015), which can effec-
tively reduce incidence of urinary tract infection and thus effec-
tively improve treatment efficiency and quality of life of
patients. At this stage, clinical use of antimicrobial agents
has been strengthened in clinics, which results in constant
change in pathogen variety and drug resistance of urinary tract
infection patients. In response to this phenomenon, emphasison pathogen detection and research in clinics should be
strengthened, effective diagnosis and treatment of suspected
cases of urinary tract infection should be done, urine culture
and sensitivity test should be actively performed, and a rela-
tively safe and effective antimicrobial agent should be selected
based on patient pathogen detection result and drug resistance
result, so as to improve clinical outcomes and promote early
recovery of patients (Qin et al., 2015).
At this stage, a certain number of patients are admitted to
hospitals every day. The great number of patients will make
spread of bacteria between patients more convenient and make
patient more easily accessible to polluted air. Some patients
have long-term treatment of bed rest, which increases the
chances of infection (August et al., 2016). Some older patients
with longer hospital stay tend to use many types of antibiotics,
which makes drug invasiveness to patients enhanced. There-
fore, pathogen detection of urinary tract infection patients
should be strengthened in clinics, in order to conduct effective
analysis of drug resistance and achieve effective treatment of
patients (Cheng, 2015).
3.3. Infection control measures
For reasons of urinary tract infections, appropriate therapeu-
tic measures should be taken for prevention and treatment of
urinary tract infection (Wang, 2015). First, intensity of basic
nursing care of patients should be strengthened. For different
types of diseases, classification diagnosis and treatment should
be conducted to avoid phenomenon of cross-infection among
patients. During hospitalization, patients’ wards should also
be ventilated, clean and tidy, in order to allow timely treatment
of patients. Meanwhile, toilet disinfection should be conducted
to prevent bacterial attack and reproduction, which can max-
imally avoid spread of bacteria, and also reduce possibility of
infection among patients (Mellotte et al., 2015). In addition,
management of hospital treatment work should be strength-
ened. In the course of treatment for patients, strict manage-
ment of therapeutic equipment should be done, and aerosol
inhalation tubes and injection utensils should be cleaned and
disinfected in a timely manner. For patients with poor physical
characteristics, necessary management of antimicrobial drugs
should also be done. Before use of antibiotics, detection of
pathogens should be strengthened and necessary drug trials
should be done to avoid infection in patients in course of med-
ication (Li and Qin, 2013).
4. Discussion and conclusion
All in all, pathogen distribution of nephrology patients with
urinary tract infections shows certain characteristics. E. coli
is one of the most important pathogens. Study of distribution
of pathogens and necessary analysis of drug resistance in
patients can provide some guidance for clinical treatment
work, enable patients to receive effective treatment, and pre-
vent disease progression in patients and thus is with very sig-
nificant clinical significance.
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